CLAREON IOL WITH THE AUTONOME DELIVERY SYSTEM
Report
- Report Number
- 9612169-2024-00452
- Event Type
- Injury
- Date Received
- May 16, 2024
- Report Date
- July 15, 2024
- Manufacturer
- ALCON LABORATORIES IRELAND LTD.
- Product Code
- HQL
- UDI-DI
- 00380652393584
- PMA / PMN Number
- P190018
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA, US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
THE PRODUCT WAS RETURNED FOR ANALYSIS. POWER AND RESOLUTION OF THE IOL WAS VERIFIED AND IS ACCEPTABLE. A READING FOR EFL (EFFECTIVE FOCAL LENGTH) OF 29.011 WAS OBTAINED. THE EFL LIMITS FOR COMPANY 13.5D MODEL ARE: EFL MIN 28.195 TO EFL MAX 29.282. THE ROOT CAUSE FOR THE REPORTED COMPLAINT COULD NOT BE DETERMINED. THE SAMPLE EVALUATION CONFIRMS THAT THE IOL IS WITHIN THE SPECIFIED RESOLUTION AND EFL RANGES FOR A COMPANY LENS. BASED ON THE RESULTS FROM THE PRODUCT HISTORY RECORD, THE PRODUCTS MET RELEASE CRITERIA. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).
INVESTIGATION INCLUDING ROOT CAUSE ANALYSIS IS IN PROGRESS. A SUPPLEMENTAL MDR WILL BE FILED AS NECESSARY IN ACCORDANCE WITH 21 CFR 803.56 WHEN ADDITIONAL REPORTABLE INFORMATION BECOMES AVAILABLE. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).
ADDITIONAL INFORMATION HAS BEEN RECEIVED THAT THE PATIENT WAS DOING WELL WITH NEW IOL OF SAME POWER.
A HEALTHCARE PROFESSIONAL REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT EXPERIENCED UNEXPECTED REFRACTIVE -7.00 D OUTCOME. ADDITIONAL INFORMATION HAS BEEN RECEIVED THAT THE REFRACTIVE SURPRISE WAS -6.50 NOW MORE THAN 1 WEEK POST OP. THE LENS WAS EXPLANTED. ADDITIONAL INFORMATION HAS BEEN REQUESTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 924993 | CLAREON IOL WITH THE AUTONOME DELIVERY SYSTEM | INTRAOCULAR LENS | HQL | ALCON LABORATORIES IRELAND LTD. | CNA0T0 | 25667641 | 00380652393584 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown | Required Intervention| O |